AusBiotech's premier medical technology investment conference, Medtech Invest 2025, opens in Sydney today.
Medtech Invest 2025 brings together sector leaders to advance breakthroughs, connect capital with opportunity, and empower the medtech sector to deliver real-world health solutions.
AusBiotech CEO Rebekah Cassidy said the investor-focused event will help accelerate the delivery of real-world, home-grown health solutions.
“With over 900 medtech companies operating in Australia, it’s clear the sector is thriving — but growth doesn’t happen without capital and investment. We’re proud to build on our strong legacy and commitment to investment, to connect innovators with the capital and connections they need to scale and succeed.”
The conference brings together a diverse delegation of Australian and international investors, medtech companies, venture capitalists, private equity leaders, brokers, analysts, executives, and global thought leaders.